Shapiro, S.: Warfarin sodium derivative (Coumadin sodium): an intravenous hypoprothrombinemia-inducing agent. Angiology,4: 370, 1953; The hypoprothrombinemia-inducing activity of warfarin sodium (Coumadin sodium). J. Kansas M. Soc.,55: 687, 1954.
2.
Clatanoff, D.V. , Triggs, P.O., AND Meyer, O.O.: Clinical experiences with warfarin and warfarin sodium. Arch. Int. Med., 94: 213, 1954.
3.
Nichol, E.S.: In Current Therapy, p. 199. W. B. Saunders Co., Philadelphia, 1954.
4.
Nichol, E.S. , Phillips, W.C., AND Valentine , E.J.: Anticoagulants in heart disease. M. Clin. NorthAmerica, 38: 399, 1954 .
5.
Pollock, B.E. : Clinical experience with warfarin (Coumadin) sodium, a new anticoagulant. J. A. M. A.,159: 1094, 1955 ; The early treatment of myocardial infarction, J. A. M. A.,161: 404, 1956.
6.
Nicholson, J.H. , AND Leavitt, T.: Coumadin (warfarin) sodium, a new anticoagulant . New England J. Med., 225: 491, 1956 .
7.
Wright, I.S., Marple, C.D., AND Beck, D.F.: Myocardial Infarction. Grune and Stratton, New York, 1954.
8.
Clatanoff, D.V. , AND Meyer, O.O.: Further observations on use of warfarin sodium in anticoagulant therapy. Arch. Int. Med. , 97: 753, 1956.
9.
Shapiro, S.: The administration of hypoprothrombinemia-inducing drugs. Angiology, 6: 500, 1955.